Show item record

dc.contributor.authorGosselin, Nadia
dc.contributor.authorBaril, Andrée-Ann
dc.contributor.authorOsorio, Ricardo S.
dc.contributor.authorKaminska, Marta
dc.contributor.authorCarrier, Julie
dc.date.accessioned2019-07-09T20:08:08Z
dc.date.availableMONTHS_WITHHELD:12fr
dc.date.available2019-07-09T20:08:08Z
dc.date.issued2019-01-15
dc.identifier.urihttp://hdl.handle.net/1866/22280
dc.publisherAmerican Thoracic Societyfr
dc.titleObstructive sleep apnea and the risk of cognitive decline in older adultsfr
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. Faculté des arts et des sciences. Département de psychologiefr
dc.identifier.doi10.1164/rccm.201801-0204PP
dcterms.abstractObstructive sleep apnea causes intermittent hypoxia and sleep fragmentation and affects at least 20% of individuals after the age of 65. There is accumulating evidence that obstructive sleep apnea may impact brain structure and function. Recent cohort studies suggest that it is a risk factor for stroke, mild cognitive impairment and Alzheimer’s disease. Because prevention through treatment of risk factors is currently the main intervention for reducing the incidence of dementia, how obstructive sleep apnea affects brain health and whether its treatment can slow neurodegeneration are relevant questions. This Perspective Article presents the most recent findings on the neurocognitive consequences of obstructive sleep apnea in the elderly. We focus on the aging brain and the link between obstructive sleep apnea, brain health, cognitive decline and dementia. We present how new discoveries from animal models, human sleep experiments, and Alzheimer’s disease biomarkers point to an active role of disturbed sleep in dementia pathogenesis. We show preliminary data on how sex, genetics, physical exercise and cognitive reserve can strengthen or weaken the association between obstructive sleep apnea and dementia. We present preliminary results of obstructive sleep apnea treatment, which can slow, stop or reverse neurodegenerative processes accentuated by obstructive sleep apnea, even in individuals already affected by a neurodegenerative disease. We propose future research directions that include studies on mild/moderate untreated obstructive sleep apnea, the evaluation of continuous positive airway pressure treatment to slow neurodegeneration and follow-up studies of older patients that measure predictors/markers of dementiafr
dcterms.isPartOfurn:ISSN:1073-449Xfr
dcterms.isPartOfurn:ISSN:1535-4970fr
dcterms.languageengfr
UdeM.ReferenceFournieParDeposantPMID: 30113864 DOI: 10.1164/rccm.201801-0204PPfr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscriptfr
oaire.citationTitleAmerican journal of respiratory and critical care medicine
oaire.citationVolume99
oaire.citationIssue2
oaire.citationStartPage142
oaire.citationEndPage148


Files in this item

Microsoft Word

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.